Home › NDC Lookup › RxCUI directory › RxCUI 1542999

168 HR buprenorphine 0.0075 MG/HR Transdermal System [BuTrans] — RxCUI 1542999

RxNorm drug concept · Semantic branded drug
RxCUI 1542999 Semantic branded drug · SBD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1542999
Official name168 HR buprenorphine 0.0075 MG/HR Transdermal System [BuTrans]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asBuTrans 7.5 MCG/HR 7 Day Transdermal Patch; Butrans 7.5 MCG/HR 7 Day Transdermal System; 168 HR BuTrans 0.0075 MG/HR Transdermal System
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)78,304 prescriptions · 32 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Buprenorphine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No, the buprenorphine transdermal patch is specifically for managing severe, persistent pain that needs continuous, around-the-clock treatment over an extended period. It's prescri...
  • What is this patch actually for — is it for addiction treatment?
  • Each patch is worn on your skin for 7 days before being swapped out. You apply it to clean, dry, intact skin on your upper outer arm, upper chest, upper back, or side of the chest....
  • How do I apply the patch, and how long does each one last?
📖 Read our full Buprenorphine Transdermal Patch guide →

🕸️ Concept Web — How 168 HR buprenorphine 0.0075 MG/HR Transdermal Sy... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 168 HR buprenorphine 0.0075 MG/HR Transdermal System [BuTrans] RxCUI 1542999

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Buprenorphine 1819
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • BuTrans 904871
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Buprenorphine Transdermal System 1806212
    • Buprenorphine Topical Product 1151364
    • Buprenorphine Transdermal Product 1295269
    • Buprenorphine Transdermal System [BuTrans] 1806214
    • BuTrans Topical Product 1168053
    • BuTrans Transdermal Product 1296477
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Buprenorphine 0.0075 MG/HR [BuTrans] SBDC · 1542998
  • Buprenorphine Transdermal System [BuTrans] SBDF · 1806214
  • BuTrans Topical Product SBDG · 1168053
  • BuTrans Transdermal Product SBDG · 1296477
  • BuTrans BN · 904871

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 1542999 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59011-0750-04 4 POUCH in 1 CARTON (59011-750-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
59011-0751-04 4 POUCH in 1 CARTON (59011-751-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
59011-0752-04 4 POUCH in 1 CARTON (59011-752-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
59011-0757-04 4 POUCH in 1 CARTON (59011-757-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
59011-0758-04 4 POUCH in 1 CARTON (59011-758-04) / 1 PATCH in 1 POUCH / 1... Butrans Knoa Pharma LLC 2011-02-14
Observed labelers: Knoa Pharma LLC (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.